James Urbanic, MD
Radiation Oncology · Encinitas, CANPI 1164607875
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,888 of the $2,473 with a category attached, or 76.3%. AstraZeneca accounts for 78.3% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2024 at $1,938 and has fallen 73.2% since, to $519 in 2025.
Across 11 payments — averaging $224.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Icotec Medical Inc.$519
- Varian Medical Systems, Inc.$17
Across 6 payments — averaging $9506.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$57K
What the payments were for
- Consulting fees$1,88876%
- Food & beverage$58624%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 2 | $1,938 |
| Icotec Medical Inc. | 8 | $519 |
| Varian Medical Systems, Inc. | 1 | $17 |
How this compares
$2,473 in reported general payments places this provider in the 75th percentile of 627 radiation oncology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine Hcl ViscousLidocaine Hcl | 24 | $353 |
| Gabapentin | 12 | $144 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 22 | $120 |
| Fluconazole | 11 | $103 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Encinitas
- Rakesh PatelLos Gatos$1.3M
- Amir LavafPalm Springs$411K
- Albert ChangLos Angeles$290K
- Arya AminiDuarte$265K
- Rizwan NuraniApple Valley$220K
- Drew MoghanakiLos Angeles$183K
- Jyoti MayadevSan Diego$170K
- Percy LeeIrvine$125K
- Felix FengSan Francisco$99K
- Hyun KimDuarte$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.